Mohammad Azab Xenon Pharmaceuticals Inc. (XENE) insider trading activity

XENE Quotes by TradingView

Mohammad Azab is of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 74,225 shares of XENE, which is worth approximately $2.95 Million. The most recent transaction as insider was on Dec 19, 2023, when has been sold 4,320 shares (Common Shares) at a price of $9.85 per share, resulting in proceeds of $42,552. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.2K
0% 3M change
6.18% 12M change
Total Value Held $2.95 Million

MOHAMMAD AZAB Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2023
BUY
Exercise of conversion of derivative security
$42,552 $9.85 p/Share
4,320 Added 5.5%
74,225 Common Shares
Dec 12 2022
BUY
Exercise of conversion of derivative security
$8,270 $2.68 p/Share
3,086 Added 4.23%
69,905 Common Shares
Dec 15 2021
BUY
Exercise of conversion of derivative security
$11,326 $3.67 p/Share
3,086 Added 4.41%
66,819 Common Shares
Dec 15 2020
BUY
Exercise of conversion of derivative security
$11,603 $3.76 p/Share
3,086 Added 4.62%
63,733 Common Shares

Also insider at

DRRX
DURECT CORP Healthcare
CLBS
CALADRIUS BIOSCIENCES, INC. Healthcare
Director
MA

Mohammad Azab

Basking Ridge, NJ

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XENE